Lijin Lin

3.0k total citations
26 papers, 221 citations indexed

About

Lijin Lin is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lijin Lin has authored 26 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 6 papers in Epidemiology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lijin Lin's work include Air Quality and Health Impacts (3 papers), Climate Change and Health Impacts (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Lijin Lin is often cited by papers focused on Air Quality and Health Impacts (3 papers), Climate Change and Health Impacts (3 papers) and Lipoproteins and Cardiovascular Health (3 papers). Lijin Lin collaborates with scholars based in China and United Kingdom. Lijin Lin's co-authors include Hongliang Li, Xuewei Huang, Zhi‐Gang She, Jingjing Cai, Fang Lei, Xingyuan Zhang, Juan‐Juan Qin, Xiao‐Jing Zhang, Peng Zhang and Weifang Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of neurosurgery and Journal of Lipid Research.

In The Last Decade

Lijin Lin

21 papers receiving 219 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lijin Lin China 10 38 37 34 32 32 26 221
Xuewei Huang China 11 54 1.4× 30 0.8× 55 1.6× 26 0.8× 32 1.0× 25 251
Geng Shen China 10 55 1.4× 36 1.0× 48 1.4× 42 1.3× 12 0.4× 31 266
Sílvia Näf Spain 9 34 0.9× 26 0.7× 77 2.3× 75 2.3× 55 1.7× 9 327
Umar Hafiz Khan India 8 15 0.4× 22 0.6× 53 1.6× 25 0.8× 14 0.4× 30 261
Wojciech Marcinkowski Poland 8 20 0.5× 18 0.5× 12 0.4× 60 1.9× 12 0.4× 40 241
Mammen Puliyel United States 9 17 0.4× 11 0.3× 48 1.4× 31 1.0× 12 0.4× 22 441
Su-Fen Qi China 12 75 2.0× 20 0.5× 50 1.5× 40 1.3× 6 0.2× 20 315
Luis Alberto Concepción‐Urteaga Peru 9 15 0.4× 9 0.2× 23 0.7× 15 0.5× 11 0.3× 44 202
Anitha Yelangi United States 3 37 1.0× 14 0.4× 20 0.6× 11 0.3× 8 0.3× 5 291

Countries citing papers authored by Lijin Lin

Since Specialization
Citations

This map shows the geographic impact of Lijin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijin Lin more than expected).

Fields of papers citing papers by Lijin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijin Lin. The network helps show where Lijin Lin may publish in the future.

Co-authorship network of co-authors of Lijin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Lijin Lin. A scholar is included among the top collaborators of Lijin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijin Lin. Lijin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Weifang, Chengzhang Yang, Fang Lei, et al.. (2025). Elevated high-density lipoprotein triglycerides increase atherosclerotic risk. Journal of Lipid Research. 66(5). 100791–100791.
2.
Huang, Jinlan, Lijin Lin, Zhou Yu, et al.. (2025). Development and validation of a machine learning model based on laboratory parameters for preoperative prediction of Ki-67 expression in gliomas. Journal of neurosurgery. 143(2). 352–364.
3.
Lin, Lijin, Fang Lei, Jianqing Zhang, et al.. (2025). Cardiovascular Health, Genetic Susceptibility, and the Risk of Incident Autoimmune Disorders in the UK Biobank: A Prospective Cohort Study. Journal of the American Heart Association. 14(10). e039451–e039451.
4.
5.
Lin, Lijin, Lei Fang, Xuewei Huang, et al.. (2024). Cardiovascular health and cancer mortality: evidence from US NHANES and UK Biobank cohort studies. BMC Medicine. 22(1). 368–368. 12 indexed citations
6.
Wang, Zhouyi, et al.. (2024). Association of urban environments with Atherosclerotic cardiovascular disease: A prospective cohort study in the UK Biobank. Environment International. 193. 109110–109110. 2 indexed citations
7.
Yang, Juan, Fang Lei, Xuewei Huang, et al.. (2024). Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank. Cardiovascular Diabetology. 23(1). 233–233. 11 indexed citations
8.
9.
Zhang, Xingyuan, Xingyuan Zhang, Ye-Mao Liu, et al.. (2023). Association between questionnaire-based and accelerometer-based physical activity and the incidence of chronic kidney disease using data from UK Biobank: a prospective cohort study. EClinicalMedicine. 66. 102323–102323. 20 indexed citations
10.
Lin, Lijin, Fang Lei, Tao Sun, et al.. (2023). Long-Term Exposure to Fine Particulate Constituents and Vascular Damage in a Population with Metabolic Abnormality in China. Journal of Atherosclerosis and Thrombosis. 30(11). 1552–1567. 8 indexed citations
11.
Zhang, Xingyuan, Jiayi Tao, Fang Lei, et al.. (2023). Association of the components of ambient fine particulate matter (PM2.5) and chronic kidney disease prevalence in China. Journal of Environmental Management. 339. 117885–117885. 13 indexed citations
12.
Lin, Lijin, Ke‐Qiong Deng, Ze Chen, et al.. (2023). Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population. Atherosclerosis. 372. 1–9. 16 indexed citations
13.
Hu, Yingying, Fan Zhou, Fang Lei, et al.. (2023). The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease. Frontiers in Endocrinology. 14. 1115354–1115354. 6 indexed citations
14.
Liu, Ye-Mao, Wenxin Wang, Xingyuan Zhang, et al.. (2023). The rising death burden of atrial fibrillation and flutter in low-income regions and younger populations. SHILAP Revista de lepidopterología. 3. 1122790–1122790. 2 indexed citations
15.
Xu, Yu, Bo Liu, Lijin Lin, et al.. (2023). The association of apolipoprotein B with chronic kidney disease in the Chinese population. Frontiers in Endocrinology. 14. 1083614–1083614. 5 indexed citations
16.
Lin, Lijin, Ye-Mao Liu, Juan‐Juan Qin, et al.. (2022). Global and Regional Trends and Projections of Infective Endocarditis-Associated Disease Burden and Attributable Risk Factors from 1990 to 2030. Chinese Medical Sciences Journal. 37(3). 181–194. 4 indexed citations
17.
Liu, Shuhua, Juan‐Juan Qin, Fang Lei, et al.. (2022). The increasing incidence and high body mass index-related burden of gallbladder and biliary diseases–A results from global burden of disease study 2019. Frontiers in Medicine. 9. 1002325–1002325. 8 indexed citations
18.
Liu, Weifang, Chengzhang Yang, Feng Wan, et al.. (2021). Risk factors for COVID-19 progression and mortality in hospitalized patients without pre-existing comorbidities. Journal of Infection and Public Health. 15(1). 13–20. 30 indexed citations
19.
Lin, Lijin, Ze Chen, Ting Ding, et al.. (2021). Newly-Diagnosed Diabetes and Sustained Hyperglycemia are Associated with Poorer Outcomes in COVID-19 Inpatients Without Pre-Existing Diabetes. Diabetes Metabolic Syndrome and Obesity. Volume 14. 4469–4482. 5 indexed citations
20.
Wu, Xiaolin, Lijin Lin, Juan‐Juan Qin, et al.. (2020). CARD3 Promotes Cerebral Ischemia‐Reperfusion Injury Via Activation of TAK1. Journal of the American Heart Association. 9(9). e014920–e014920. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuewei Huang Breakdown of academic impact, for papers by Geng Shen Breakdown of academic impact, for papers by Sílvia Näf Breakdown of academic impact, for papers by Umar Hafiz Khan Breakdown of academic impact, for papers by Wojciech Marcinkowski Breakdown of academic impact, for papers by Mammen Puliyel Breakdown of academic impact, for papers by Su-Fen Qi Breakdown of academic impact, for papers by Luis Alberto Concepción‐Urteaga Breakdown of academic impact, for papers by Anitha Yelangi
Rankless by CCL
2026